Aveanna Healthcare (AVAH) Q1 2026 earnings review
Volume Surges, but Margin Compression Points to a Slower Year Ahead
Aveanna kicked off 2026 with a top-line beat, driving revenue to $647.9M (+15.9% YoY) on the back of impressive volume gains in its core segments. However, the volume growth is masking a significant gross margin squeeze. In the core Private Duty Services (PDS) segment, wage inflation heavily outpaced revenue rate growth, compressing overall company gross margins by 110 basis points to 31.7%. Management raised full-year FY26 guidance, but the implied growth rates for the remainder of the year point to a sharp deceleration in both sales and earnings as labor costs cap profitability.
🐂 Bull Case
Volume is booming. PDS hours grew 10.7% and Home Health episodes jumped 23.1% YoY. The aggressive pivot to value-based care and MCOs is securing the volume needed to fuel top-line expansion.
After struggling through early 2025, the Medical Solutions segment saw gross margins expand by 200 bps to 44.7%, proving management's modernization efforts are taking root.
🐻 Bear Case
PDS cost per hour grew 8.1%, while revenue per hour grew only 5.7%. Aveanna is handing virtually all of its rate increases directly to caregivers to secure labor, destroying gross margin expansion.
Despite a strong Q1, the midpoint of the newly raised FY26 Adjusted EBITDA guidance ($330M) implies just 2.8% YoY growth for the year—a massive deceleration from the 74.8% growth delivered in FY25.
⚖️ Verdict: ⚪
Neutral. Top-line volume execution is undeniably excellent. But trading 140 bps of gross margin in your largest segment for volume is a fragile strategy. Combined with $1.48B in debt and decelerating guidance, the margin profile makes this a 'show me' story for the back half of 2026.
Key Themes
Wage Pass-Throughs Crush PDS Gross Margins
A major red flag emerged in the Private Duty Services (PDS) segment. While revenue grew an impressive 16.4%, gross margin fell from 29.3% to 27.9%. The math is simple and concerning: the cost of revenue rate grew 8.1% (to $32.05/hour) while the revenue rate grew only 5.7% (to $44.43/hour). The 'spread rate' was entirely flat at $12.38. This confirms that Aveanna currently lacks the pricing power to outpace wage inflation, relying solely on volume for absolute gross profit dollar growth.
Home Health Episodic Mix Strategy Succeeds
The Home Health & Hospice (HHH) segment delivered a stellar volume quarter, with total episodes growing 23.1% YoY. More importantly, the critical 'episodic mix' metric hit 80.9%, up from 77.3% a year ago and breaking past management's historical >75% targets. This deliberate shift toward episodic payers is successfully shielding the segment's gross margins (steady at 53.7%).
Medical Solutions Returns to Profitable Growth
Medical Solutions (MS) successfully reversed its historical stagnation. Unique patients served (UPS) grew 4.5% YoY to 93,000. Unlike PDS, the MS segment demonstrated positive operating leverage: revenue per patient increased 2.9% while the cost rate actually declined 0.9%, driving the spread rate up 8.1%. This confirms that the preferred payor strategy is finally working in MS.
Family First Homecare Acquisition Upside
Management highlighted the pending acquisition of Family First Homecare, expected to be funded via cash and the securitization facility. Crucially, this acquisition is excluded from the current FY26 guidance. If closed smoothly, it provides a built-in catalyst to beat the newly raised targets in the second half of the year, expanding Aveanna's density in the high-demand Florida market.
Cash Flow Remains Structurally Weak in Q1
Free cash flow for Q1 was negative $3.8M. While this is an improvement from negative $12.9M in Q1 2025 and is historically a seasonally weak quarter due to payroll taxes, the company carries $1.48B in total indebtedness. Aveanna cannot afford execution missteps when operating with this level of leverage and zero Q1 free cash flow buffer.
Other KPIs
Stable sequentially. High leverage remains the primary structural risk for the stock. However, interest rate exposure is aggressively hedged ($520M in fixed swaps, $880M capped at 2.96% SOFR), which locked in interest expense at $29.2M for the quarter—a manageable level given the $84.4M in Adjusted EBITDA, but still a heavy drag on net income.
Stable. The absolute dollar profit made per hour of care in the PDS segment was $12.38, completely flat YoY vs $12.37 in 25Q1. This highlights the reality of Aveanna's current labor dynamics: any rate enhancements won from government affairs are immediately being passed through to caregivers just to maintain headcount.
Guidance
Decelerating YoY. While management raised the range from previous estimates, the midpoint of $2.57B implies ~5.6% YoY growth against FY25's $2.433B. This is a sharp slowdown from the 20.2% growth achieved in FY25 and the 15.9% growth printed in 26Q1, suggesting volume will normalize lower through the year.
Decelerating sharply. The midpoint of $330M implies just 2.8% YoY growth compared to FY25's $320.9M. Because Q1 already generated $84.4M (+25.2% YoY), this guidance implies that Q2-Q4 Adjusted EBITDA will effectively flatline or decline compared to 2025 levels. This is a highly cautious outlook that reflects ongoing margin compression.
Key Questions
Margin Floor for PDS
With PDS cost per hour (+8.1%) growing significantly faster than revenue per hour (+5.7%), what is the internal floor for PDS gross margin, and at what point do you halt volume growth if it becomes dilutive to margin profiles?
Implied Q2-Q4 Deceleration
Q1 Adjusted EBITDA grew 25%, but the full-year guidance implies essentially zero YoY EBITDA growth for the remaining three quarters. Is this purely conservatism pending the Family First integration, or are there specific labor or rate headwinds expected in the back half of the year?
Leverage Impact of M&A
Given the negative free cash flow in Q1 and the pending cash/securitization funding of the $175.5M Family First Homecare deal, what is the expected peak net leverage ratio immediately following the close?